Cytogen (217330) Stock Overview

Cytogen, Inc., a biotechnology company, develops and sells CTC (circulating tumor cell) enrichment and downstream systems to treat cancer in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immune florescence staining systems; and cell image analyzers, which help capture and analyze multi-fluorescence images with multi-channel image sensors and cameras. It also provides time laps incubators, which help monitoring cell growth and capture cell images from the cell culture plates. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was incorporated in 2010 and is headquartered in Seoul, South Korea.